TY - JOUR
T1 - Evaluation of (2S,4S)/(2R,4R) and (2S,4R)/(2R,4S) 6,6-N,N-dimethyl-2-methyl-2-oxo-1,3-dioxa-4-hexadecyl-6,aza-2-phosphacyc looctane bromide as inhibitors for protein kinase C, carnitine octanoyltransferase, and carnitine palmitoyltransferase
AU - Kumaravel, G.
AU - Nic a' Bháird, N.
AU - Fronczek, F. R.
AU - Ramsay, R. R.
AU - Ashendel, C. L.
AU - Gandour, R. D.
PY - 1994/1/1
Y1 - 1994/1/1
N2 - (2S,4S)/(2R,4R) and (2S,4R)/(2R,4S) 6,6-N,N-dimethyl-2-methyl-2-oxo-1,3-dioxa-4-hexadecyl-6-aza-2-phosphacyc looctane bromide strongly inhibited protein kinase C and moderately inhibited carnitine octanoyltransferase and carnitine palmitoyltransferase.
AB - (2S,4S)/(2R,4R) and (2S,4R)/(2R,4S) 6,6-N,N-dimethyl-2-methyl-2-oxo-1,3-dioxa-4-hexadecyl-6-aza-2-phosphacyc looctane bromide strongly inhibited protein kinase C and moderately inhibited carnitine octanoyltransferase and carnitine palmitoyltransferase.
UR - http://www.scopus.com/inward/record.url?scp=0028224398&partnerID=8YFLogxK
U2 - 10.1016/S0960-894X(01)80256-0
DO - 10.1016/S0960-894X(01)80256-0
M3 - Article
AN - SCOPUS:0028224398
SN - 0960-894X
VL - 4
SP - 883
EP - 886
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 7
ER -